Skip to content

The study for remote ischemic preconditioning on postoperative cognitive dysfunction in elderly patients: a prospective, single-center, randomized, double-blind, controlled study

The neuroprotective effect and translational research of remote ischemic preconditioning on chronic cerebral ischemia injury

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035020
Enrollment
Unknown
Registered
2020-07-28
Start date
2020-08-01
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative cognitive dysfunction

Interventions

Remote preconditioning group:Remote ischemic preconditioning
Control group:Cuff compression but no ischemic preconditioning
Sham group:Nil

Sponsors

Xijing Hospital of Air Force Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. From July 2020, Xijing Hospital of Air Force Military Medical University admitted patients who were scheduled to undergo surgery under general anesthesia; 2. Patients with operation time >= 2 h; 3. Patients aged over 60 years old; 4. American Society of anesthesiologists (ASA): Grade II ~ III; 5. Patients who have signed informed consent form; 6. The non-surgical control group was age and gender matched non-surgical outpatients in the same period.

Exclusion criteria

Exclusion criteria: 1. Patients with degenerative diseases of central nervous system, including dementia, Alzheimer's disease and Parkinson's disease; 2. Neurobehavioral assessment was performed within three months; 3. Patients with mental illness who need treatment; 4. Mini Mental State Examination MMSE 2 mg / dl, i.e. 176.82 µ mol / L); 9. Patients with liver diseases (AST, ALT 1.5 times higher than the normal upper limit); 10. Patients who are unable to comply with or unwilling to cooperate; 11. Patients who are unable to complete the procedure according to instructions; 12. Patients with unclear understanding of the language used in the study; 13. Patients with severe visual or hearing impairment; 14. Patients with alcohol or drug dependence (drinking more than 5u a day in the past three months, 1U is equal to 10ml or 8g pure alcohol, equivalent to more than 100ml of liquor of > 50 degree, two liang); 15. Patients who have participated in this study or other clinical studies at the same time.

Design outcomes

Primary

MeasureTime frame
POCD incidence;Serum MD2 and CystatinC levels;The relative risk of allelic locus mutations and POCD;

Secondary

MeasureTime frame
The variability of the methylation gene sequencing of the target region of the patient's nucleic acid level;

Countries

China

Contacts

Public ContactHailong Dong

Department of Anesthesia and Perioperative Medicine, Xijing Hospital of Air Force Military Medical University

hldong6@hotmail.com+86 13669226699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026